- Home
- ESPR vs PKBK Comparison
ESPR vs PKBK Comparison
Compare ESPR & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- PKBK
- Stock Information
- Founded
- ESPR 2008
- PKBK 1999
- Country
- ESPR United States
- PKBK United States
- Employees
- ESPR N/A
- PKBK N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- PKBK Major Banks
- Sector
- ESPR Health Care
- PKBK Finance
- Exchange
- ESPR Nasdaq
- PKBK Nasdaq
- Market Cap
- ESPR 220.0M
- PKBK 256.4M
- IPO Year
- ESPR 2013
- PKBK N/A
- Fundamental
- Price
- ESPR $2.17
- PKBK $22.25
- Analyst Decision
- ESPR Buy
- PKBK
- Analyst Count
- ESPR 6
- PKBK 0
- Target Price
- ESPR $6.50
- PKBK N/A
- AVG Volume (30 Days)
- ESPR 5.2M
- PKBK 27.0K
- Earning Date
- ESPR 08-05-2025
- PKBK 10-17-2025
- Dividend Yield
- ESPR N/A
- PKBK 3.39%
- EPS Growth
- ESPR N/A
- PKBK 42.58
- EPS
- ESPR N/A
- PKBK 2.56
- Revenue
- ESPR $268,125,000.00
- PKBK $66,879,999.00
- Revenue This Year
- ESPR $6.10
- PKBK N/A
- Revenue Next Year
- ESPR N/A
- PKBK N/A
- P/E Ratio
- ESPR N/A
- PKBK $8.29
- Revenue Growth
- ESPR N/A
- PKBK 3.52
- 52 Week Low
- ESPR $0.69
- PKBK $16.94
- 52 Week High
- ESPR $3.94
- PKBK $24.29
- Technical
- Relative Strength Index (RSI)
- ESPR 73.45
- PKBK 62.96
- Support Level
- ESPR $2.00
- PKBK $21.23
- Resistance Level
- ESPR $2.14
- PKBK $22.24
- Average True Range (ATR)
- ESPR 0.15
- PKBK 0.49
- MACD
- ESPR 0.02
- PKBK 0.05
- Stochastic Oscillator
- ESPR 95.08
- PKBK 98.67
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.